Moreover, in GSE26713, the expression level of IRF8 was relatively lower in T‐ALL patient cohorts with homeobox A (HOXA)‐activating rearrangement, which is considered an adverse prognostic factor, than in patients with T‐ALL and those with other genetic abnormalities (Figure 1C). The gene discussed is IRF8; the disease is acute lymphoblastic leukemia.